Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2025-08-05 00:00:00 ET · period of report 2025-08-01 · accession 0000950170-25-102977 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2025-08-05 | 2025-08-01 | TEVA | Hughes Eric A | See "Remarks" | S - Sale+OE | $15.16 | -52.7K | 0 | -100% | -$799.6K |
| DT | 2025-08-05 | 2025-08-01 | TEVA | Hughes Eric A | See "Remarks" | M - OptEx | — | +52.7K | 52.7K | New | — |
| DT | 2025-08-05 | 2025-08-01 | TEVA | Hughes Eric A | See "Remarks" | M - OptEx | $0.00 | -52.7K | 52.7K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-08-01 | S | D | 52,742 | $15.16 | 0 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.13 to $15.31, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Ordinary Shares | 2025-08-01 | M | A | 52,742 | — | 52,742 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Derivative | Restricted Share Units | 2025-08-01 | M | D | 52,742 | $0.00 | 52,744 | D | — · — to — | 52,742 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F5) Restricted share units were granted on August 1, 2022, with 52,742 vested on each of August 1, 2023, August 1, 2024 and August 1, 2025, and 52,744 vesting on August 1, 2026. |